LMAN2 Promotes Breast Cancer Tumorigenesis and Drug Resistance by Interacting With MAPK9 via Activation of the MAPK Pathway
ABSTRACT Introduction Breast cancer (BC) is the most prevalent malignancy among women worldwide. Lectin, mannose‐binding 2 (LMAN2) is a cargo receptor engaged in the transport and sorting of glycoproteins. Despite its ubiquity, the function and underlying mechanisms of LMAN2 in BC continue to elude...
Saved in:
| Main Authors: | Chen Feng, Pingping Li, Pengtao Liu, Bo Wang, Juan Li, Peijun Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.70448 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PELI2 inhibits colorectal cancer development through MAPK signaling pathway
by: Jialin Liu, et al.
Published: (2025-06-01) -
GRB2 promotes brain metastasis in HER2-positive breast cancer by regulating the Ras/MAPK pathway
by: Hongyu Li, et al.
Published: (2025-04-01) -
FAK mediates BMP9-induced osteogenic differentiation via Wnt and MAPK signaling pathway in synovial mesenchymal stem cells
by: Weiwei Zheng, et al.
Published: (2019-12-01) -
The mechanisms of melanogenesis inhibition by glabridin: molecular docking, PKA/MITF and MAPK/MITF pathways
by: Chunxing Pan, et al.
Published: (2023-01-01) -
Molecular Markers for Thyroid Cancer Diagnosis: Insights from MAPK Pathway Gene Expression Analysis
by: Breno Pupin, et al.
Published: (2025-06-01)